Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/12942
DC FieldValueLanguage
dc.contributor.authorHalimi Vesaen_US
dc.contributor.authorDaci Armonden_US
dc.contributor.authorSimona Stojanovskaen_US
dc.contributor.authorPanovska-Stavridis Irinaen_US
dc.contributor.authorMilena Stevanovicen_US
dc.contributor.authorFilipce Venkoen_US
dc.contributor.authorGrozdanova, Aleksandraen_US
dc.date.accessioned2021-05-31T12:21:23Z-
dc.date.available2021-05-31T12:21:23Z-
dc.date.issued2020-05-16-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/12942-
dc.language.isoenen_US
dc.publisherJournal of Pharmaceutical Policy and Practiceen_US
dc.titleCurrent regulatory approaches for accessing potential COVID-19 therapiesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s40545-020-00222-6-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Files in This Item:
File Description SizeFormat 
s40545-020-00222-6.pdf488.99 kBAdobe PDFView/Open
Show simple item record

Page view(s)

58
checked on Apr 26, 2024

Download(s)

11
checked on Apr 26, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.